Chen, Q.* ; Zheng, J. ; Wang, D.* ; Liu, Q.* ; Kang, L.* ; Gao, X.* ; Lin, Z.*
Nitrosonisoldipine is a selective inhibitor of inflammatory caspases and protects against pyroptosis and related septic shock.
Eur. J. Immunol. 51, 1234-1245 (2021)
Pyroptosis is a type of acute cell death that mainly occurs in immune cells. It is characterized with robust release of inflammatory cytokines and has emerged to play a critical role in the pathogenesis of sepsis-associated immune disorders. In this study, we screened for pyroptotic inhibitors with the ultimate goal to benefit sepsis treatments. Accidentally, we identified nitrosonisoldipine (NTS), a photodegradation product of calcium channel inhibitor nisoldipine, blocking non-canonical pyroptosis. Using murine immortalized bone-marrow derived macrophage and human THP-1 cell line, we further discovered that NTS not only inhibits non-canonical pyroptosis mediated by caspase-11 or caspase-4, but also canonical pyroptosis mediated by caspase-1. Mechanistically, NTS directly inhibits the enzyme activities of these inflammatory caspases, and these inhibitory effects persist despite extensive washout of the drug. By contrast, apoptosis mediated by caspase-3/-7 was not affected by NTS. Mice pretreated with NTS intraperitoneally displayed improved survival rate and extended survival time in LPS- and polymicrobe-induced septic models respectively. In conclusion, NTS is a selective inhibitor of inflammatory caspases which blocks both the non-canonical and canonical pyroptotic pathways. It is safe for intraperitoneal administration and might be used as a prototype to develop drugs for sepsis treatments.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Nitrosonisoldipine ⋅ Pyroptosis ⋅ Septic Shock ⋅ Caspases ⋅ Inflammation
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
0014-2980
e-ISSN
1521-4141
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 51,
Heft: 5,
Seiten: 1234-1245
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
Hoboken
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-506900-001
Förderungen
Collaborative Innovation of Industry, University, and Research Institute Major Program of Guangzhou
Fundamental Research Funds for the Central Universities
Natural Science Foundation of Jiangsu Province
National Natural Science Foundation of China
Ministry of Science and Technology of China
Copyright
Erfassungsdatum
2021-03-30